Literature DB >> 28233697

FIGO stage IB1 cervical carcinoma: Place and principles of brachytherapy.

A Huertas1, S Oldrini2, J-P Nesseler2, F Courrech2, P Rétif3, C Charra-Brunaud2, D Peiffert2.   

Abstract

The treatment of cervical cancers according to FIGO staging is well defined. For FIGO stage IB2 or more, chemoradiotherapy followed by uterovaginal brachytherapy boost is the standard treatment. Surgery is the preferred choice for less advanced tumors. However, most French institutions propose preoperative brachytherapy followed by hysterectomy with pelvic lymphadenectomy for FIGO stage IB1 tumors over 2cm. Brachytherapy is also used for the boost after adjuvant pelvic external beam radiotherapy. Tridimensional dosimetry with optimization allows better treatment planning, delivering high doses to target volumes with limited irradiation to the organs at risk. We will discuss the indications of brachytherapy for FIGO stage IB1 tumors and the principles of pulsed-dose rate and high-dose rate techniques.
Copyright © 2017 Société française de radiothérapie oncologique (SFRO). Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Brachytherapy; Cancer du col utérin; Cervical cancer; Colpohystérectomie; Curiethérapie; HDR; Hysterectomy; Optimization; PDR

Mesh:

Year:  2017        PMID: 28233697     DOI: 10.1016/j.canrad.2016.09.014

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  2 in total

1.  Stereotactic Body Radiation Therapy Boost in Patients With Cervical Cancer Ineligible for Brachytherapy.

Authors:  Giuseppe Facondo; Gianluca Vullo; Vitaliana DE Sanctis; Maurizio Valeriani; Anna Maria Ascolese; Maria Massaro; Dimitri Anzellini; Mattia Falchetto Osti
Journal:  Cancer Diagn Progn       Date:  2021-05-03

2.  Pre-operative high-dose-rate brachytherapy in early-stage cervical cancer: long-term single-center results.

Authors:  Sylwia Kellas-Ślęczka; Piotr Wojcieszek; Marta Szlag; Magdalena Stankiewicz; Agnieszka Cholewka; Maciej Ślęczka; Agnieszka Badora-Rybicka; Piotr Lelek; Agnieszka Pruefer; Tomasz Krzysztofiak; Zofia Kołosza; Marek Fijałkowski
Journal:  J Contemp Brachytherapy       Date:  2022-01-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.